Clinical Trial Update: A Study to Show That the Change of Attention Measure is Correlated With the Changes of Caregiver's Burden After Treatment With Galantamine in Patients With Alzheimer's Disease

View source ↗

Summary

A completed study investigating whether changes in attention with galantamine treatment correlate with changes in caregiver burden in Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Galantamine (galantamine)

Snippet

Sponsor: Janssen Korea, Ltd., Korea | Conditions: Alzheimer's Disease | Status: COMPLETED | Results posted: 2013-08-05